Disappointing iPhone X demand weighed the markets down to a lower open with the Dow falling 39 points to 24,715. Nasdaq dropped 31 points to 6,928.

On the upside

Stock News Journal wrote that Kohl's (NYSE: KSS) was undervalued.

Mallinckrodt (NYSE: MNK) will pay approximately $840 million to acquire Sucampo Pharmaceuticals (Nasdaq: SCMP).

All sale items at Macy's (NYSE: M) have been discounted an extra 20%.

On the downside

Weak demand for the Apple iPhone X (Nasdaq: AAPL) weighed down share of Micron Technology (Nasdaq: MU).

The Food and Drug Administration extended its review period for Portola Pharmaceuticals' (Nasdaq: PTLA) AndexXa.

Investors continued to lock in profits on Skyworks Solutions (Nasdaq: SWKS).

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE while decliners edged out advancers by nearly 9 to 8 on Nasdaq. The broader S&P 500 slipping 4 points to 2,679. Bitcoin leaped $1,979 to $15,780.